MiRNA-200b reverses drug resistance of hepatocellular carcinoma HepG2 cells to sorafenib and its underlying mechanism

Objective To explore the effect of miRNA-200b on sorafenib resistance in hepatocellular carcinoma cells in order to increase the efficacy of the drug in advanced liver cancer patients. Methods Sorafenib resistant hepatocellular carcinoma HepG2-SR cell line was established by gradually increasing th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: DENG Yong, TANG Tengqian, ZHANG Leida
Formato: article
Lenguaje:ZH
Publicado: Editorial Office of Journal of Third Military Medical University 2021
Materias:
Acceso en línea:https://doaj.org/article/ebebf18ffa6548c1a4574feac02cd3e2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!